Renin-angiotensin blockade reduces serum free testosterone in middle-aged men on haemodialysis and correlates with erythropoietin resistance

Nephrology Dialysis Transplantation

Volumn 20, Issue 3, 2005, Pages 585-590

  DeLong, Michael ^a   Logan, Joy L ^a   Yong, Kim Chong ^a   Lien, Yeong Hau H ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Anaemia; Erythrotopoietin; Haemodialysis; Renin angiotensin system; Testosterone

Indexed keywords

ALBUMIN; ANDROGEN; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; FERRITIN; HEMOGLOBIN; PARATHYROID HORMONE; TESTOSTERONE;

ADULT; AGE DISTRIBUTION; AGED; ANEMIA; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG DOSE REGIMEN; ENZYME IMMUNOASSAY; FEMALE; HEMODIALYSIS; HORMONE DETERMINATION; HUMAN; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEX DIFFERENCE; TESTOSTERONE BLOOD LEVEL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CASE-CONTROL STUDIES; DRUG RESISTANCE; EPOETIN ALFA; FEMALE; HEMATINICS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; SEX FACTORS; TESTOSTERONE;

EID: 15044351513     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh638     Document Type: Article

References (20)

1. Gossman J, Burkhardt R, Harder S et al. Angiotensin II infusion increases plasma erythropoietin levels via an angiotensin II type I receptor-dependent pathway. Kidney Int 2001; 60: 83-86
2. Vlahakos DV, Balodimos C, Papachristopoulos V et al. Renin-angiotensin system stimulates erythropoietin secretion in chronic hemodialysis patients. Clin Nephrol 1995; 43: 53-59
3. Albitar S, Genin R, Fen-Chong M et al. High dose enalapril impairs the response to erythropoietin treatment in haemodialysis patients. Nephrol Dial Transplant 1998; 13: 1206-1210
4. Hayashi K, Hasegawa K, Kobayashi S. Effects of angiotensin-converting enzyme inhibitors on the treatment of anemia with erythropoietin. Kidney Int 2001; 60: 1910-1916
5. Schwarzbeck A, Wittenmeier KW, Hallfrizsch U. Anemia in dialysis patients as a side effect of sartanes. Lancet 1998; 352: 286
6. Lang SM, Schiffl. H. Losartan and anaemia of end stage renal disease. Lancet 1998; 352: 1708
7. Ifudu O, Uribarri J, Rajwani I et al. Gender modulates responsiveness to recombinant erythropoietin. Am J Kidney Dis 2001; 38: 518-522
8. Koshida H, Takeda R, Miyamori I. Lisinopril decreases plasma free testosterone in male hypertensive patients and increases sex hormone binding globulin in female hypertensive patients. Hyperten Res Clin Exp 1998; 21: 279-282
9. Harman SM, Metter EJ, Tobin JD et al. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocr Metab 2001; 86: 724-731
10. Teruel JL, Marcen R, Navarro JF et al. Evolution of serum erythropoietin after androgen administration to hemodialysis patients: a prospective study. Nephron 1995; 70: 282-286
11. Navaro JF, Mora C, Macia M et al. Randomized prospective comparison between erythropoietin and androgens in CAPD patients. Kidney Int 2002; 61: 1537-1544
12. Gaughan WJ, Liss KA, Dunn SR et al. A 6 month study of low-dose recombinant human erythropoietin alone and in combination with androgens for the treatment of anemia in chronic hemodialysis patients. Am J Kidney Dis 1997; 30: 495-500
13. Berns JS, Rudnick MR, Cohen RM. A controlled trial of recombinant human erythropoietin and nandrolone decanoate in the treatment of anemia in patients on chronic hemodialysis. Clin Nephrol 1992; 37: 264-267
14. Foresta C, Mioni R, Bordon P et al. Erythropoietin stimulates testosterone production in man. J Clin Endocr Metab 1994; 78: 753-756
15. Kokot F, Wiecek A, Grzeszczak W et al. Influence of erythropoietin treatment on follitropin and lutropin response response to luliberin and plasma testosterone levels in hemodialyzed patients. Nephron 1990; 56: 126-129
16. Abu-Alfa AK, Perazella MA. Angiotensin-converting enzyme inhibitors and anemia in chronic kidney disease: a complex interaction. Am J Kidney Dis 2002; 39: 896-897
17. Le Meur Y, Lorgeot V, Comte L et al. Plasma levels of metabolism of AcSDKP in patients with chronic renal failure: relationship with erythropoietin requirements. Am J Kidney Dis 2001; 38: 510-517
18. Schiffl H, Lang SM. Angiotensin converting enzyme inhibitors but not angiotensin II AT1 receptor antagonists affect erythropoiesis in patients with anemia of end stage renal disease. Nephron 1999; 81: 106-108
19. Hacihanefioglu B, Somunkiran A, Mahmutoglu I et al. Effect of hypertension therapy with the angiotensin-converting enzyme inhibitor lisinopril on hyperandrogenism in women with polycystic ovary syndrome. Fert Ster 2002; 77: 526-528
20. Vlahakos DV, Marathias KP, Agroyannis B et al. Posttransplant erythrocytosis. Kidney Int 2003; 63: 1194-1197